Literature DB >> 17355465

Severe hepatitis C virus-related cryoglobulinaemic sensory-motor polyneuropathy treated with pegylated interferon-a2b and ribavirin: clinical, laboratory and neurophysiological study.

J Koskinas1, C Kilidireas, N Karandreas, D Kountouras, S Savvas, E Hadziyannis, A J Archimandritis.   

Abstract

BACKGROUND/AIMS: Severe involvement of central and/or peripheral nervous system is a rare complication of hepatitis C virus (HCV)-related cryoglobulinaemia.
METHOD: Four patients with HCV-related type II/III cryoglobulinaemia (three males with genotype 1, one female with genotype 3) who presented with severe sensory-motor polyneuropathy, one with central nervous system involvement as well, were treated with pegylated IFNa-2b 1.5 microg/kg/week and ribavirin 10.6 mg/kg/daily for 48 weeks. Neurological evaluation involved detailed clinical motor and sensory scores/scales and neurophysiological studies before and after treatment. RESULTS/
CONCLUSION: Three out of four patients had undetectable serum HCV-RNA, normal levels of aminotransferases and substantially lower or undetectable levels of cryoglobulins at the end of treatment and at 24 weeks follow-up period. Treatment was well tolerated and all patients exhibited significant improvement of neuropathy based on solid clinical and laboratory criteria that was associated with the virological response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17355465     DOI: 10.1111/j.1478-3231.2006.01436.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  5 in total

Review 1.  Extrahepatic immune related manifestations in chronic hepatitis C virus infection.

Authors:  Maria Tampaki; John Koskinas
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

2.  Sensory neuropathy in patients with cryoglobulin negative hepatitis-C infection.

Authors:  Min-Suk Yoon; Mark Obermann; Christina Dockweiler; Roland Assert; Ali Canbay; Sebastian Haag; Guido Gerken; Hans-Christoph Diener; Zaza Katsarava
Journal:  J Neurol       Date:  2010-08-04       Impact factor: 4.849

3.  Rituximab in cryoglobulinemic peripheral neuropathy.

Authors:  Roberto Cavallo; Dario Roccatello; Elisa Menegatti; Carla Naretto; Franca Napoli; Simone Baldovino
Journal:  J Neurol       Date:  2009-03-05       Impact factor: 4.849

4.  Hepatitis C, stigma and cure.

Authors:  Rui Tato Marinho; David Pires Barreira
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

5.  Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection.

Authors:  Mahmoud Aboelneen Khattab; Mohammed Eslam; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2010-12-01       Impact factor: 0.660

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.